ARCHIVES

Nexavar Phase III Trial Fails To Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI Last Month Are Listed

April 25, 2003

NCCS Networker Volume 5 Issue 4, Fall 1991

September 13, 1991

More Bad News For Estrogen: Increased Ovarian Cancer Risk

July 19, 2002

NCI Not Following Congress Mandate, Zubrod Contends

April 28, 1978

Advocacy. Bypass Budget Treated As Serious Funding Request By Advocates

January 30, 1998

CCOP Recompetition Approved By NCAB

May 23, 1986